ADIPOQ
ADIPOQ encodes adiponectin, an insulin-sensitizing hormone secreted exclusively by adipocytes. Higher levels correlate with reduced risk of type 2 diabetes and cardiovascular disease, acting primarily through AMPK activation.
Key Takeaways
- •ADIPOQ encodes adiponectin, the most abundant hormone secreted by healthy fat cells.
- •Adiponectin is a powerful insulin sensitizer that directly activates AMPK in the liver and muscle.
- •Paradoxically, adiponectin levels fall as fat mass increases, contributing to obesity-related metabolic disease.
- •Higher adiponectin levels are strongly associated with cardiovascular health and a lower risk of Type 2 Diabetes.
Basic Information
- Gene Symbol
- ADIPOQ
- Full Name
- Adiponectin, C1Q And Collagen Domain Containing
- Also Known As
- GBP28apM1ADPN
- Location
- 3q27.3
- Protein Type
- Peptide Hormone
- Protein Family
- C1q/TNF-related Protein Family
Related Isoforms
Key SNPs
One of the most widely studied variants; associated with altered circulating adiponectin levels and risk for metabolic syndrome.
Influences the transcriptional rate of the ADIPOQ gene and is linked to cardiovascular disease risk.
Overview
The ADIPOQ gene encodes adiponectin, a 244-amino acid protein that serves as a master regulator of systemic insulin sensitivity and energy homeostasis. Unlike most hormones secreted by adipose tissue (adipokines), which increase with obesity and drive inflammation, adiponectin is secreted exclusively by adipocytes and its circulating levels decrease as fat mass expands.
Adiponectin circulates in the blood in multiple oligomeric forms: low-molecular-weight (LMW) trimers, medium-molecular-weight (MMW) hexamers, and high-molecular-weight (HMW) multimers. The HMW form is considered the most metabolically active. By binding to its receptors (AdipoR1 and AdipoR2), adiponectin stimulates fatty acid oxidation and glucose uptake, while simultaneously suppressing inflammation and hepatic glucose production.
Conceptual Model
A simplified mental model for the pathway:
Adiponectin is the signal that tells the rest of the body the fat stores are healthy and metabolic fuel is available.
Core Health Impacts
- • Insulin sensitization: Directly improves the cellular response to insulin in liver and muscle.
- • Anti-inflammatory: Suppresses TNF-α and other pro-inflammatory cytokines.
- • Anti-atherogenic: Protects blood vessels by inhibiting plaque formation and improving nitric oxide.
- • Fatty acid oxidation: Promotes the burning of fats via AMPK activation.
- • Liver protection: Reduces hepatic fat accumulation and prevents steatosis (NASH/MASH).
Upstream Regulators
PPARγ Activator
The master transcription factor for adipogenesis; directly binds the ADIPOQ promoter to increase expression.
FoxO1 Activator
Upregulates adiponectin during fasting to coordinate the metabolic shift to fat burning.
TNF-α Inhibitor
Inflammatory cytokine from large fat cells that potently suppresses adiponectin production.
IL-6 Inhibitor
Another obesity-linked cytokine that contributes to the decline of adiponectin in metabolic syndrome.
Downstream Targets
AdipoR1 / AdipoR2 Activates
Transmembrane receptors that mediate adiponectin signals in muscle and liver.
AMPK Activates
The master energy sensor; activated by adiponectin to drive catabolic fat burning.
Ceramidase Activates
AdipoR activation stimulates ceramidase activity, clearing lipotoxic ceramides.
p38 MAPK Activates
Activated downstream of AdipoR2 to regulate fatty acid oxidation and glucose uptake.
NF-κB Inhibits
Adiponectin suppresses this master inflammatory switch, reducing systemic inflammaging.
Role in Aging
Adiponectin is often called a "longevity hormone" because its levels remain high in centenarians and its signaling opposes almost all hallmarks of metabolic aging.
Centenarian Marker
High circulating adiponectin, particularly the HMW form, is a consistent biomarker of exceptionally long-lived individuals.
Anti-Inflammaging
By suppressing NF-κB and TNF-α, adiponectin acts as a systemic brake on the chronic low-grade inflammation that characterizes aging.
Proteostatic Support
Adiponectin-driven AMPK activation supports autophagy, helping cells clear the protein aggregates that accumulate over time.
Vascular Aging
It protects the endothelial lining from age-related stiffening and oxidative stress, maintaining cardiovascular flexibility.
Disorders & Diseases
Metabolic Syndrome
Hypoadiponectinemia (low levels) is a core feature of the cluster including hypertension, dyslipidemia, and central obesity.
Type 2 Diabetes
Low adiponectin levels often precede the development of T2D and are a strong predictor of future insulin resistance.
Cardiovascular Disease
Low levels are associated with increased risk of myocardial infarction and coronary artery disease.
Lipodystrophy
Rare disorders of fat distribution where the lack of healthy adipose tissue leads to near-zero adiponectin and severe metabolic damage.
Interventions
Supplements
High doses of EPA and DHA have been shown in multiple trials to modestly increase adiponectin levels.
May enhance adiponectin expression by modulating PPARγ and reducing systemic inflammatory pressure.
Reported to stimulate the ADIPOQ promoter and improve oligomerization into active HMW forms.
Lifestyle
The most effective way to raise adiponectin; as fat cells shrink, they become more metabolically healthy and secrete more hormone.
Independent of weight loss, regular exercise improves adiponectin sensitivity and circulating concentrations.
Activation of brown fat and acute cold stress can transiently increase adiponectin secretion.
Medicines
Powerful PPARγ agonist that can double or triple circulating adiponectin levels.
Indirectly raise adiponectin levels primarily through their effects on weight loss and reduced fat cell size.
A synthetic small-molecule adiponectin receptor agonist currently under research for metabolic and longevity benefits.
Lab Tests & Biomarkers
Activity Markers
Standard measure; levels below 4 µg/mL are associated with significantly increased metabolic risk.
Measures the most active high-molecular-weight form; a better predictor of insulin sensitivity than total levels.
A robust marker of adipose tissue health; a falling ratio indicates worsening metabolic syndrome.
Hormonal Interactions
Insulin Synergist
Adiponectin clears the path for insulin to work efficiently; its loss is the definition of insulin resistance.
Leptin Counter-Regulatory
Leptin signals the *quantity* of fat, while adiponectin signals the *quality* of fat.
Cortisol Antagonist
Chronic stress and high cortisol suppress adiponectin secretion, contributing to stress-induced metabolic dysfunction.
Deep Dive
Network Diagrams
Adiponectin Signaling Relay
Adipose Tissue Health & ADIPOQ
Activation Mechanics: The AdipoR Relay
Adiponectin signals through two primary atypical GPCRs: AdipoR1 (highly expressed in muscle) and AdipoR2 (predominant in the liver). These receptors do not signal via G-proteins like most GPCRs; instead, they serve as metabolic transducers.
The intracellular tail of the AdipoR receptors binds to an adapter protein called APPL1. This binding initiates a dual-pathway response. First, it activates AMPK, which triggers the burning of fats and the uptake of glucose. Second, it activates ceramidase, an enzyme that breaks down ceramides—toxic lipids that “jam” the insulin receptor. By clearing these clogs, adiponectin restores the natural flow of insulin signaling.
The Paradox of Obesity and Adiponectin
In almost every other hormone system, a larger tissue mass leads to higher hormone secretion. Adiponectin is the grand exception. As fat cells (adipocytes) grow larger in obesity (hypertrophy), they become stressed and hypoxic.
These stressed cells begin secreting inflammatory cytokines like TNF-α. TNF-α binds receptors on the same adipocytes and triggers a “transcriptional shutdown” of the ADIPOQ gene. Consequently, precisely when the body needs more adiponectin to handle the excess lipid load, the production of the hormone crashes. This collapse is a defining molecular event in the transition from simple obesity to full-blown metabolic syndrome.
Oligomers and Biological Potency
The function of adiponectin is dictated by its shape. It is initially synthesized as a monomer but must assemble into complex structures to work.
The High-Molecular-Weight (HMW) multimer consists of 12 to 18 monomers. This large complex has the highest affinity for AdipoR1 and is the form that most powerfully lowers blood sugar. Clinical studies show that the ratio of HMW adiponectin to total adiponectin is a more accurate predictor of metabolic health and longevity than the total level alone. High HMW levels are a “hallmark” of centenarian metabolism.
Relevant Research Papers
Links go to PubMed (abstracts are public); some papers also offer free full text via PMC or the publisher.
Seminal paper demonstrating adiponectin as an endogenous insulin sensitizer.
Identified AdipoR1 and AdipoR2, revealing the pathway to AMPK activation and ceramide reduction.